Cingulate Gears Up for NDA Filing as It Advances ADHD Medication Development
Sep 4, 2024
Adhd Stock Market Invest
Cingulate Inc. Secures European Patent for ADHD Medication CTx-1301
Aug 15, 2024
Cingulate Inc. Shares Surge on Positive FDA Guidance for ADHD Drug Candidate
Dec 29, 2023